Largest
Global site network embedded into community care
Powering research, accelerating outcomes
We bring GI & Hepatology research directly into the communities where care happens, connecting sponsors’ scientific ambition with empowered, high-performing research sites. Together, we accelerate time to market for life-changing therapies while expanding access for the patients who need them most.
Iterative Health Site Network:
Where elite sites drive innovation forward
By placing sites at the center, we power a global performance-driven network
with exceptional patient reach trusted by both Sponsors/CROs and Providers
to accelerate life-changing GI and Hepatology therapies to market.
with exceptional patient reach trusted by both Sponsors/CROs and Providers
to accelerate life-changing GI and Hepatology therapies to market.
Strategic Partners
We’re proud to partner with two leading provider networks, GI Alliance and One GI, to expand access to clinical trials across community-based practices and accelerate the advancement of new therapies for patients.
Powering a network that delivers
We help investigators and sponsors run clinical trials more efficiently,
accelerating enrollment, reducing operational burden, and
delivering reliable results at scale.
accelerating enrollment, reducing operational burden, and
delivering reliable results at scale.
0+
Research
sites
sites
0M
Patient
reach
reach
0X
Patient
enrollment rate
enrollment rate
0X
Faster site
activation
activation
Empowering sites and sponsorsto accelerate discovery
Partner with Iterative Health to streamline clinical trials, expand
patient access, and leverage AI-powered tools that help sites and
sponsors move research forward efficiently and effectively.
Providers
Grow your research ancillary with access to top-tier studies, support for operational excellence, and innovative AI technology to supercharge patient enrollments
Explore Site Network
Sponsors & CROs
Partner with the performance-driven global site network that delivers confident site selection, unparalleled activation speed, and industry-leading patient enrollments
Explore partnershipsAccessible research, life-changing results
Clinical trials are more than research, they’re treatment options embedded into community care. Hear from Bruce, a patient with IBD, about his participation in clinical research and the impact of our strategic partnership with GI Alliance
Join our team
Interested in joining our mission to accelerate life-changing therapies to market?
Explore careersResources and insights in clinical research
Learn from experts, case studies, and best practices that are driving faster, more efficient,
and patient-focused clinical trials in GI, hepatology, and beyond
and patient-focused clinical trials in GI, hepatology, and beyond
A Closer Look at Dr. DuVall’s Clinical Leader Article on Accelerating Clinical Trials
Dr. DuVall outlines how specialized, community-based research sites reduce study activation time, expand patient access, and improve trial execution by embedding research directly into everyday care settings, demonstrating why integrated clinics are critical to delivering faster, higher-quality clinical research in today’s increasingly complex trial landscape.
Learn More
Building Sustainable Clinical Research Sites, Why the Future of Clinical Trials Depends on It: Interview with Dana Feuchtbaum
Dana discusses why sustainable clinical research sites are essential to the future of trials, highlighting staffing challenges, operational strain, and how strategic investment in people, processes, and partnerships can strengthen sites and accelerate patient access to life-changing therapies
Learn More
Case Study: How Gastro One Accelerated a Complex Phase 1b-A GI Trial with Iterative Health
This case study shows how Gastro One, with Iterative Health’s support, accelerated a complex Phase 1b-A GI trial by streamlining operations, improving patient retention, and increasing randomizations. Targeted, high-touch support, from proactive chart reviews to regulatory guidance, reduced team burden and delivered faster enrollment and measurable trial efficiency.
Learn More
Latest news
Business WireFebruary 12, 2026
Iterative Health Appoints Nadege Gunn, MD, as Chief Medical Officer, Hepatology and Obesity
Business WireSeptember 30, 2025
Iterative Health Appoints Bill Kayser as President and Chief Financial Officer
Business WireAugust 26, 2025
Iterative Health and One GI Announce Strategic Partnership, Advancing Research as a Driver of Care Innovation
Connect with us to
advance clinical research
Reach out to learn more about our solutions, partnerships, and career opportunities.
Get in touch